Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review.
about
Toxicity of MRI and CT contrast agentsTailoring encodable lanthanide-binding tags as MRI contrast agentsPerfusion cardiovascular magnetic resonance: Comparison of an advanced, high-resolution and a standard sequence.Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs.Fluorinated dendrimers as imaging agents for ¹⁹F MRI.Contrast agents for MRI: 30+ years and where are we going?Are the increasing amounts of gadolinium in surface and tap water dangerous?A simple approach to a new T8-POSS based MRI contrast agent.Gadofullerene MRI contrast agents.A metal-coded affinity tag approach to quantitative proteomics.Nuclear microscopy: a novel technique for quantitative imaging of gadolinium distribution within tissue sections.Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imagingN-acetylcysteine protects rats with chronic renal failure from gadolinium-chelate nephrotoxicity.Type of MRI contrast, tissue gadolinium, and fibrosis.Is the transport of a gadolinium-based contrast agent decreased in a degenerated or aged disc? A post contrast MRI studyOn the use of molecular weight cutoff cassettes to measure dynamic relaxivity of novel gadolinium contrast agents: example using hyaluronic Acid polymer complexes in phosphate-buffered salineT1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.Gadolinium-based contrast agents: did we miss something in the last 25 years?Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.An extracellular MRI polymeric contrast agent that degrades at physiological pHGadolinium and nephrogenic systemic fibrosis: time to tighten practice.Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in JapanBiochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.Gadolinium and nephrogenic systemic fibrosis: association or causation.Pathophysiology of gadolinium-associated systemic fibrosisCellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease.Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.Metal complexation chemistry used for phosphate and nucleotide determination: an investigation of the Yb3+-pyrocatechol violet sensor.Capillary electrophoretic methods in the development of metal-based therapeutics and diagnostics: new methodology and applications.Nephrogenic systemic fibrosis: concepts and perspectives.Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents.Electrophoretic separation techniques and their hyphenation to mass spectrometry in biological inorganic chemistry.Novel heterobimetallic radiotheranostic: preparation, activity, and biodistribution.Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice.Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agentsSynthesis of europium-doped VSOP, customized enhancer solution and improved microscopy fluorescence methodology for unambiguous histological detection.
P2860
Q22306013-2A159AAA-3BF7-418E-A2C8-297E58486C9FQ27683418-BC4D885F-1301-40BE-9ABF-9072EEF91CB5Q30522019-379924A4-847A-485B-85C9-6D481A850E94Q30568297-13BBF809-3C05-4E52-BCE2-7117A16DF6FDQ30660527-385C64B9-1C50-4A59-B3F7-88BB59FD29B6Q30731463-B64B0978-7F06-4875-B680-540EA65A8E4CQ31128062-3384ECB4-783C-45D4-961A-F1973F692C6BQ31135238-1CB3E345-D85A-4F29-98D6-E7B7E98C6504Q31150936-F1F0958B-1C75-4312-A295-9206E7003F9AQ33290709-C9B02D69-E63B-4905-B115-95DF2376A9ABQ33574781-A78A5085-8C45-4D7F-8D2D-2A1159BE3019Q34205213-6280B505-E144-470A-91A4-B09CB9E2ECF0Q34344717-F0226E28-1755-4A65-9DBB-1CA71E2F5A3DQ34602036-FEBF4DF8-CD05-4F9C-9FEA-1BCDF4BA14AFQ35022920-AC53761B-1DCC-410B-968C-B8F95F390425Q35608648-49E14686-28B1-48E1-B0DA-104F9477E043Q35827906-72A4C3CB-5FC2-46CB-8E09-91BA60044D7EQ35878856-0A37CCCB-F578-49B4-8FDB-4742E19C33FAQ36059081-1B5A5FA9-10C7-4FB9-A634-F339CEAB429FQ36148570-1E8C1411-1B47-4DBC-8A9D-D54733693C3AQ36236679-06B4AFBC-823E-4B4F-BC6C-DB8B0A77FEFBQ36538610-379ACEAD-1367-4843-A0D2-E33E7EB23FDEQ36555396-5F428121-0103-4DBF-9CD7-E98A378CB6EEQ36564222-11982558-0777-41F0-97B6-A86A062E81ACQ36649891-C9FC828B-287C-47B6-827C-4DBD8CDB20E9Q36985258-FE279D8C-E165-4A1B-A49A-90AF49E3A2D0Q37067538-AE309F1D-C9B1-41AA-8BA0-29F58AD85B30Q37139482-37F13781-CFDC-4639-8359-618E103D81E9Q37209833-E2D4CB8C-C8E6-4141-8F1A-A8506A3E1870Q37219177-388A068E-61E3-4116-8352-FE7AEFA189F6Q37425774-9F79E5CF-59D0-4BCE-8BB0-0F2AE2463E3DQ37997361-FE60415F-A07F-4396-8356-F46EF45609C9Q38034645-BBEDD9F0-3CBD-478E-8D4C-CA068F326913Q38210490-6CAF36E5-DD97-4F10-A1BE-827A582CC374Q38661389-F184A8A1-C157-48B5-8356-E9BD3EEE9CF1Q39031995-19CFDDF4-07D7-4F36-ADF5-89D3086FB2D2Q39587499-879BDED5-5743-4451-859B-00C81208A6CDQ41391342-1C0596C4-5024-42B6-8156-011BF60C6D25Q42061581-CEE6EC80-2377-43CC-84E9-5A4E02664F37Q42374097-6154BE72-37DF-4853-ACB0-050334F0B6BF
P2860
Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Clinical and biological conseq ...... c resonance imaging: a review.
@ast
Clinical and biological conseq ...... c resonance imaging: a review.
@en
type
label
Clinical and biological conseq ...... c resonance imaging: a review.
@ast
Clinical and biological conseq ...... c resonance imaging: a review.
@en
prefLabel
Clinical and biological conseq ...... c resonance imaging: a review.
@ast
Clinical and biological conseq ...... c resonance imaging: a review.
@en
P2093
P2860
P1476
Clinical and biological conseq ...... c resonance imaging: a review.
@en
P2093
Claire Corot
Isabelle Raynal
Jean-Marc Idée
Michel Schaefer
Soizic Le Greneur
P2860
P304
P356
10.1111/J.1472-8206.2006.00447.X
P577
2006-12-01T00:00:00Z